Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies

Clinics in Dermatology

Volumn 31, Issue 4, 2013, Pages 438-454

  Gambichler, Thilo ^a   Terras, Sarah ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; TACROLIMUS;

ARTICLE; ATOPIC DERMATITIS; CLINICAL PROTOCOL; CUTANEOUS T CELL LYMPHOMA; ERYTHEMA; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HUMAN; HYPERPIGMENTATION; LICHEN SCLEROSUS ET ATROPHICUS; MYCOSIS FUNGOIDES; NECROBIOSIS LIPOIDICA; PATIENT SAFETY; PHOTODERMATOSIS; PHOTOTHERAPY; PHOTOTHERAPY DEVICE; PITYRIASIS ROSEA; POMPHOLYX; PRIORITY JOURNAL; PRURIGO; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SARCOIDOSIS; SCLERODERMA; SUNBURN; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; URTICARIA PIGMENTOSA;

DERMATITIS, ATOPIC; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY DOSAGE; SCLERODERMA, LOCALIZED; SKIN DISEASES; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; URTICARIA PIGMENTOSA;

EID: 84879562959     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.01.011     Document Type: Article

References (144)

1. Plewig G., Hofmann C., Braun-Falco O., Nath G., Kreitmair A. A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications. Br J Dermatol 1978, 98:15-24.
2. Mutzhas M.F., Holzle E., Hofmann C., Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol 1981, 76:42-47.
3. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000, 25:552-558.
4. Gambichler T., Al-Muhammadi R., Boms S. Immunologically mediated photodermatoses: diagnosis and treatment. Am J Clin Dermatol 2009, 10:169-180.
5. Kroft E.B., Berkhof N.J., van de Kerkhof P.C., Gerritsen R.M., de Jong E.M. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008, 59:1017-1030.
6. Gambichler T. Management of atopic dermatitis using photo(chemo)therapy. Arch Dermatol Res 2009, 301:197-203.
7. Jacobe H.T., Cayce R., Nguyen J. UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V. Br J Dermatol 2008, 159:691-696.
8. Rombold S., Lobisch K., Katzer K., Grazziotin T.C., Ring J., Eberlein B. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol Photoimmunol Photomed 2008, 24:19-23.
9. Meduri N.B., Vandergriff T., Rasmussen H., Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007, 23:106-112.
10. Pavel S. Light therapy (with UVA-1) for SLE patients: is it a good or bad idea?. Rheumatology (Oxford) 2006, 45:653-655.
11. Dawe R.S. Ultraviolet A1 phototherapy. Br J Dermatol 2003, 148:626-637.
12. Tuchinda C., Kerr H.A., Taylor C.R., et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed 2006, 22:247-253.
13. Suh K.S., Kang J.S., Baek J.W., et al. Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases. Ann Dermatol 2010, 22:1-8.
14. York N.R., Jacobe H.T. UVA1 phototherapy: a review of mechanism and therapeutic application. Int J Dermatol 2010, 49:623-630.
15. Baron E.D., Stevens S.R. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003, 16:303-310.
16. Lim H.W., Hönigsmann H., Hawk J.L.M. Photodermatology 2007, Informa Healthcare USA Inc., New York.
17. von Kobyletzki G., Pieck C., Hoffmann K., Freitag M., Altmeyer P. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999, 41:931-937.
18. Polderman M.C., Wintzen M., le Cessie S., Pavel S. UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center. Photodermatol Photoimmunol Photomed 2005, 21:93-96.
19. Brem R., Karran P. Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine. Photochem Photobiol 2011, 88:5-13.
20. Beattie P.E., Dawe R.S., Ferguson J., Ibbotson S.H. Dose-response and time-course characteristics of UV-A1 erythema. Arch Dermatol 2005, 141:1549-1555.
21. Dogra S., De D. Phototherapy and photochemotherapy in childhood dermatoses. Indian J Dermatol Venereol Leprol 2010, 76:521-526.
22. Kerr A.C., Ferguson J., Attili S.K., et al. Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report. Clin Exp Dermatol 2012, 37:219-226.
23. Krutmann J., Czech W., Diepgen T., Niedner R., Kapp A., Schopf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992, 26:225-230.
24. Krutmann J., Diepgen T.L., Luger T.A., et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998, 38:589-593.
25. Tzaneva S., Seeber A., Schwaiger M., Honigsmann H., Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001, 45:503-507.
26. Dittmar H.C., Pflieger D., Schopf E., Simon J.C. UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis. Hautarzt 2001, 52:423-427.
27. Kowalzick L., Kleinheinz A., Weichenthal M., et al. Low dose versus medium dose UV-A1 treatment in severe atopic dermatitis. Acta Derm Venereol 1995, 75:43-45.
28. Kowalzick L., Ponnighaus J.M., Suckow M., Waldmann T. Responders and nonresponders of ultraviolet A-1 therapy of acute exacerbated atopic dermatitis. Hautarzt 1997, 48:645-647.
29. Abeck D., Schmidt T., Fesq H., et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000, 42:254-257.
30. Legat F.J., Hofer A., Brabek E., Quehenberger F., Kerl H., Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003, 139:223-224.
31. Gambichler T., Othlinghaus N., Tomi N.S., et al. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic dermatitis: a randomized crossover study. Br J Dermatol 2009, 160:652-658.
32. Majoie I.M., Oldhoff J.M., van Weelden H., et al. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009, 60:77-84.
33. Tzaneva S., Kittler H., Holzer G., et al. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial. Br J Dermatol 2010, 162:655-660.
34. Petering H., Breuer C., Herbst R., Kapp A., Werfel T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic dermatitis. J Am Acad Dermatol 2004, 50:68-72.
35. Schmidt T., Abeck D., Boeck K., Mempel M., Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand dermatitis. Acta Derm Venereol 1998, 78:318-319.
36. Polderman M.C., Govaert J.C., le Cessie S., Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic dermatitis. Clin Exp Dermatol 2003, 28:584-587.
37. Krutmann J., Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc 1999, 4:70-72.
38. Morita A., Werfel T., Stege H., et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997, 186:1763-1768.
39. Breuckmann F., von Kobyletzki G., Avermaete A., et al. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Eur J Med Res 2002, 7:315-322.
40. Breuckmann F., von Kobyletzki G., Avermaete A., Kreuter A., Altmeyer P., Gambichler T. Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy. BMC Dermatol 2002, 2:12.
41. Gambichler T., Kreuter A., Tomi N.S., Othlinghaus N., Altmeyer P., Skrygan M. Gene expression of cytokines in atopic dermatitis before and after ultraviolet A1 phototherapy. Br J Dermatol 2008, 158:1117-1120.
42. von Kobyletzki G., Uhle A., Pieck C., Hoffmann K., Altmeyer P. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol 2000, 136:275-276.
43. Morita A., Kobayashi K., Isomura I., Tsuji T., Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000, 43:670-674.
44. Sawada H., Isogai Z., Morita A. Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases. BMC Dermatol 2003, 3:2.
45. Kreuter A., Breuckmann F., Uhle A., et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004, 50:740-747.
46. Pereira N., Santiago F., Oliveira H., Figueiredo A. Low-dose UVA(1) phototherapy for scleroderma: what benefit can we expect?. J Eur Acad Dermatol Venereol 2012, 26:619-626.
47. Rose R.F., Turner D., Goodfield M.J., Goulden V. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Photodermatol Photoimmunol Photomed 2009, 25:153-155.
48. Tewari A., Garibaldinos T., Lai-Cheong J., Groves R., Sarkany R., Branislav Novakovic L. Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis. Photodermatol Photoimmunol Photomed 2011, 27:113-114.
49. Durand F., Staumont D., Bonnevalle A., Hachulla E., Hatron P.Y., Thomas P. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis. Photodermatol Photoimmunol Photomed 2007, 23:215-221.
50. Comte C., Bessis D., Picot E., Peyron J.L., Guillot B., Dereure O. Treatment of connective tissue disorder-related acral syndromes using UVA-1 phototherapy. An open study of 11 cases. Ann Dermatol Venereol 2009, 136:323-329.
51. Stege H., Berneburg M., Humke S., et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997, 36:938-944.
52. Kerscher M., Dirschka T., Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995, 346:1166.
53. Gruss C.J., Von Kobyletzki G., Behrens-Williams S.C., et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001, 17:149-155.
54. Camacho N.R., Sanchez J.E., Martin R.F., Gonzalez J.R., Sanchez J.L. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001, 45:697-699.
55. de Rie M.A., Enomoto D.N., de Vries H.J., Bos J.D. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003, 207:298-301.
56. Kreuter A., Hyun J., Stucker M., Sommer A., Altmeyer P., Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006, 54:440-447.
57. Sator P.G., Radakovic S., Schulmeister K., Honigsmann H., Tanew A. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol 2009, 60:786-791.
58. Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, et al. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma. Int J Dermatol;50:1006-13.
59. Andres C., Kollmar A., Mempel M., Hein R., Ring J., Eberlein B. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Br J Dermatol 2010, 162:445-447.
60. Gruss C., Stucker M., Kobyletzki G., Schreiber D., Altmeyer P., Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997, 136:293-294.
61. Kreuter A., Jansen T., Stucker M., et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001, 26:30-32.
62. Kreuter A., Gambichler T., Avermaete A., et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002, 46:251-255.
63. Beattie P.E., Dawe R.S., Ferguson J., Ibbotson S.H. UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol 2006, 31:343-347.
64. Grundmann-Kollmann M., Behrens S., Gruss C., Gottlober P., Peter R.U., Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000, 42:134-136.
65. Stander H., Schiller M., Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002, 46:799-800.
66. Calzavara Pinton P., Porta F., Izzi T., et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica 2003, 88:1169-1175.
67. Wetzig T., Sticherling M., Simon J.C., Hegenbart U., Niederwieser D., Al-Ali H.K. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplant 2005, 35:515-519.
68. Schlaak M., Schwind S., Wetzig T., et al. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin. Bone Marrow Transplant 2010, 45:1741-1748.
69. Ziemer M., Thiele J.J., Gruhn B., Elsner P. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life. J Am Acad Dermatol 2004, 51:318-319.
70. Tran K.T., Prather H.B., Cockerell C.J., Jacobe H. UV-A1 therapy for nephrogenic systemic fibrosis. Arch Dermatol 2009, 145:1170-1174.
71. Kafi R., Fisher G.J., Quan T., et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004, 140:1322-1324.
72. Kreuter A., Gambichler T., Weiner S.M., Schieren G. Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis. Arch Dermatol 2008, 144:1527-1529.
73. Gazi H., Pope J.E., Clements P., et al. Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol 2007, 34:501-509.
74. Kreuter A., Gambichler T. UV-A1 phototherapy for sclerotic skin diseases: implications for optimizing patient selection and management. Arch Dermatol 2008, 144:912-916.
75. Breuckmann F., Gambichler T., Altmeyer P., Kreuter A. UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol 2004, 4:11.
76. Gambichler T., Skrygan M., Tomi N.S., Altmeyer P., Kreuter A. Differential expression of decorin in localized scleroderma following ultraviolet-A1 irradiation. J Am Acad Dermatol 2007, 56:956-959.
77. Kreuter A., Hyun J., Skrygan M., et al. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma. Arch Dermatol Res 2006, 298:265-272.
78. Kreuter A., Hyun J., Skrygan M., et al. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol 2006, 155:600-607.
79. Yin L., Yamauchi R., Tsuji T., Krutmann J., Morita A. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J Dermatol 2003, 30:173-180.
80. Gambichler T., Skrygan M., Tomi N.S., Breuksch S., Altmeyer P., Kreuter A. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation. Br J Dermatol 2007, 156:951-956.
81. Plettenberg H., Stege H., Megahed M., et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999, 41:47-50.
82. Zane C., Leali C., Airo P., De Panfilis G., Pinton P.C. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001, 44:629-633.
83. Stander H., Schwarz T. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma?. J Am Acad Dermatol 2000, 43:881.
84. von Kobyletzki G., Dirschka T., Freitag M., Hoffman K., Altmeyer P. Ultraviolet-A1 phototherapy improves the status of the skin in cutaneous T-cell lymphoma. Br J Dermatol 1999, 140:768-769.
85. Calzavara-Pinton P., Venturini M., Sala R. Medium-dose UVA1 therapy of lymphomatoid papulosis. J Am Acad Dermatol 2005, 52:530-532.
86. Kreuter J.A., Gambichler T., Jansen T., Hoffmann K., Altmeyer P., von Kobyletzki G. UVA1 cold-light phototherapy of small plaque parapsoriasis. Acta Derm Venereol 2000, 80:390-391.
87. Roupe G. Hypopigmented mycosis fungoides in a child successfully treated with UVA1-light. Pediatr Dermatol 2005, 22:82.
88. Oberholzer P.A., Cozzio A., Dummer R., French L.E., Hofbauer G.F. Granulomatous slack skin responds to UVA1 phototherapy. Dermatology 2009, 219:268-271.
89. von Kobyletzki G., Heine O., Stephan H., et al. UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo. Photodermatol Photoimmunol Photomed 2000, 16:271-277.
90. Breuckmann F., von Kobyletzki G., Avermaete A., Kreuter A., Altmeyer P. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Photodermatol Photoimmunol Photomed 2002, 18:217-222.
91. McGrath H. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994, 12:129-135.
92. McGrath H., Martinez-Osuna P., Lee F.A. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 1996, 5(4):269-274.
93. Polderman M.C., Huizinga T.W., Le Cessie S., Pavel S. UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 2001, 60:112-115.
94. Polderman M.C., le Cessie S., Huizinga T.W., Pavel S. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) 2004, 43:1402-1404.
95. Molina J.F., McGrath H. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997, 24:1072-1074.
96. Menon Y., McCarthy K., McGrath H. Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus. Lupus 2003, 12:479-482.
97. McGrath H. Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient. Lupus 2005, 14:859-861.
98. Szegedi A., Simics E., Aleksza M., et al. Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005, 44:925-931.
99. Polderman M.C., van Kooten C., Smit N.P., Kamerling S.W., Pavel S. Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro. Clin Exp Immunol 2006, 145:528-534.
100. Mikita N., Kanazawa N., Yoshimasu T., et al. The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL/lpr mice. Clin Dev Immunol 2009, 67:39-52.
101. Sonnichsen N., Meffert H., Kunzelmann V., Audring H. UV-A-1 therapy of subacute cutaneous lupus erythematosus. Hautarzt 1993, 44:723-725.
102. Mitra A., Yung A., Goulden V., Goodfield M.D. A trial of low-dose UVA1 phototherapy for two patients with recalcitrant discoid lupus erythematosus. Clin Exp Dermatol 2006, 31:299-300.
103. Stege H., Schopf E., Ruzicka T., Krutmann J. High-dose UVA1 for urticaria pigmentosa. Lancet 1996, 347:64.
104. Stege H., Budde M., Kürten V. Induction of apoptosis in skin-infiltrating mast cells by high-dose ultraviolet-A-1 (UVA-1) radiation phototherapy in patients with urticaria pigmentosa. J Invest Dermatol 1999, 112:561.
105. Gobello T., Mazzanti C., Sordi D., et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003, 49:679-684.
106. Kowalzick L., Holig O., Waldmann T., Suckow M., Ott A., Pönnighaus J.M. Versagen von Mittel- und Hochdosis-UV-A1 bei zwei Fällen von Urticaria pigmentosa. Akt Dermatol 1999, 25:389-391.
107. Radakovic S., Weber M., Tanew A. Dramatic response of chronic ulcerating necrobiosis lipoidica to ultraviolet A1 phototherapy. Photodermatol Photoimmunol Photomed 2010, 26:327-329.
108. Beattie P.E., Dawe R.S., Ibbotson S.H., Ferguson J. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol 2006, 31:235-238.
109. Mahnke N., Medve-Koenigs K., Berneburg M., Ruzicka T., Neumann N.J. Cutaneous sarcoidosis treated with medium-dose UVA1. J Am Acad Dermatol 2004, 50:978-979.
110. Graefe T., Konrad H., Barta U., Wollina U., Elsner P. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001, 145:354-355.
111. Muchenberger S., Schopf E., Simon J.C. Phototherapy with UV-A-I for generalized granuloma annulare. Arch Dermatol 1997, 133:1605.
112. Frigerio E., Franchi C., Garutti C., Spadino S., Altomare G.F. Multiple localized granuloma annulare: ultraviolet A1 phototherapy. Clin Exp Dermatol 2007, 32:762-764.
113. Schnopp C., Tzaneva S., Mempel M., Schulmeister K., Abeck D., Tanew A. UVA1 phototherapy for disseminated granuloma annulare. Photodermatol Photoimmunol Photomed 2005, 21:68-71.
114. Gambichler T., Hyun J., Sommer A., Stucker M., Altmeyer P., Kreuter A. A randomised controlled trial on photo(chemo)therapy of subacute prurigo. Clin Exp Dermatol 2006, 31:348-353.
115. Lim S.H., Kim S.M., Oh B.H., et al. Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea. Ann Dermatol 2009, 21:230-236.
116. Rucker B.U., Haberle M., Koch H.U., Bocionek P., Schriever K.H., Hornstein O.P. Ultraviolet light hardening in polymorphous light eruption-a controlled study comparing different emission spectra. Photodermatol Photoimmunol Photomed 1991, 8:73-78.
117. von Kobyletzki G., Kreuter J.A., Nordmeier R., Stucker M., Altmeyer P. Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 2000, 201:76-77.
118. Plotz S.G., Abeck D., Seitzer U., Hein R., Ring J. UVA1 for hypereosinophilic syndrome. Acta Derm Venereol 2000, 80:221.
119. Schaller M., Romiti R., Wollenberg A., Prinz B., Woerle B. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol 2001, 45:969-970.
120. Pinton P.C., Capezzera R., Zane C., De Panfilis G. Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002, 47:410-414.
121. Eberlein-Konig B., Vogel M., Katzer K., et al. Successful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol 2005, 19:203-204.
122. Kroft E.B., de Jong E.M. Scleredema diabeticorum case series: successful treatment with UV-A1. Arch Dermatol 2008, 144:947-948.
123. Kochs C., Bockmann A., Hanneken S., Neumann N.J. Scleredema diabeticorum: successful treatment with UVA-1 phototherapy. Hautarzt 2011, 62:255-257.
124. Capezzera R., Venturini M., Bianchi D., Zane C., Calzavara-Pinton P. UVA1 phototherapy of Netherton syndrome. Acta Derm Venereol 2004, 84:69-70.
125. Karamfilov T., Buslau M., Durr C., Weyers W. Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents. Hautarzt 2003, 54:448-452.
126. Meewes C., Henrich A., Krieg T., Hunzelmann N. Treatment of reticular erythematous mucinosis with UV-A1 radiation. Arch Dermatol 2004, 140:660-662.
127. Kroft E.B., van de Kerkhof P.C., Gerritsen M.J., de Jong E.M. Period of remission after treatment with UVA-1 in sclerodermic skin diseases. J Eur Acad Dermatol Venereol 2008, 22:839-844.
128. Janiga J.J., Ward D.H., Lim H.W. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed 2004, 20:210-211.
129. Hannuksela-Svahn A., Grandal O.J., Thorstensen T., Christensen O.B. UVA1 for treatment of keloids. Acta Derm Venereol 1999, 79:490.
130. Asawanonda P., Khoo L.S., Fitzpatrick T.B., Taylor C.R. UV-A1 for keloid. Arch Dermatl 1999, 135:348-349.
131. Silny W., Osmola-Mankowska A., Czarnecka-Operacz M., Zaba R., Danczak-Pazdrowska A., Marciniak A. Eosinophilic fascitis: a report of two cases treated with ultraviolet A1 phototherapy. Photodermatol Photoimmunol Photomed 2009, 25:325-327.
132. Phototherapy and Photodiagnostic Methods 2001, Springer-Verlag, Berlin. J. Krutmann, H. Hönigsmann, C. Elmets, P.R. Bergstresser (Eds.).
133. Behrens S., Reuther T., von Kobyletzki G., et al. Bleomycin-induced PSS-like pseudoscleroderma. Case report and review of the literature. Hautarzt 1998, 49:725-729.
134. Herbst R.A., Vogelbruch M., Ehnis A., Kiehl P., Kapp A., Weiss J. Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br J Dermatol 2000, 142:574-575.
135. El-Zawahry B.M., Bassiouny D.A., Sobhi R.M., et al. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2012, 28:84-90.
136. Halliday G.M., Byrne S.N., Damian D.L. Ultraviolet A radiation: its role in immunosuppression and carcinogenesis. Semin Cutan Med Surg 2011, 30:214-221.
137. Damian D.L., Matthews Y.J., Phan T.A., Halliday G.M. An action spectrum for ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2011, 164:657-659.
138. Park J., Halliday G.M., Surjana D., Damian D.L. Nicotinamide prevents ultraviolet radiation-induced cellular energy loss. Photochem Photobiol 2010, 86:942-948.
139. Calzavara-Pinton P., Monari P., Manganoni A.M., et al. Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases. Photodermatol Photoimmunol Photomed 2010, 26:263-265.
140. Besaratinia A., Kim S.I., Bates S.E., Pfeifer G.P. Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C. Proc Natl Acad Sci U S A 2007, 104:5953-5958.
141. Brem R., Daehn I., Karran P. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation. DNA Repair (Amst) 2011, 10:869-876.
142. Wang F., Garza L.A., Cho S., et al. Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy. Arch Dermatol 2008, 144:851-858.
143. Zandi S., Kalia S., Lui H. UVA1 phototherapy: a concise and practical review. Skin Therapy Lett 2012, 17:1-4.
144. Silber S. A new and rapid scoring system to assess the scientific evidence from clinical trials. J Intervent Cardiol 2006, 19:485-492.